Profile
Craig Bottomley is the founder of Halcygen Pharmaceuticals Ltd., which was founded in 2005.
He held the title of Chief Operating Officer & Executive Director from 2005 to 2010.
Mr. Bottomley's former jobs include Managing Director at GUD Holdings Ltd., Director at Mirrabooka Investments Ltd., Managing Director at Pacific Dunlop Cables Group, and Non-Executive Director at BWX Ltd.
from 2013 to 2017.
He also held the position of Non-Executive Director at Star Combo Pharma Ltd.
in 2019.
Former positions of Craig Bottomley
Companies | Position | End |
---|---|---|
STAR COMBO PHARMA LIMITED | Director/Board Member | 2019-08-15 |
BWX | Director/Board Member | 2017-03-01 |
Halcygen Pharmaceuticals Ltd.
Halcygen Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Halcygen Pharmaceuticals Ltd. engages in development and licensing of new improved proprietary generic formulations known as Super Generics or High Functionality Generics. Halcygen Pharmaceuticals products includes: Suba Itraconazole is a super-bioavailable formulation of itraconazole, a synthetic broad-spectrum anti-fungal agent and Minocycline is used to treat bacterial infections including respiratory tract infections, infections of skin, genital and urinary systems. The company is headquartered in Melbourne, Australia. | Founder | 2010-11-21 |
MAYNE PHARMA GROUP LIMITED | Chief Operating Officer | 2010-07-28 |
GUD HOLDINGS LIMITED | Chief Executive Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 4 |
---|---|
MAYNE PHARMA GROUP LIMITED | Health Technology |
BWX | Consumer Non-Durables |
GUD HOLDINGS LIMITED | Consumer Durables |
STAR COMBO PHARMA LIMITED | Health Technology |
Private companies | 3 |
---|---|
Halcygen Pharmaceuticals Ltd.
Halcygen Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Halcygen Pharmaceuticals Ltd. engages in development and licensing of new improved proprietary generic formulations known as Super Generics or High Functionality Generics. Halcygen Pharmaceuticals products includes: Suba Itraconazole is a super-bioavailable formulation of itraconazole, a synthetic broad-spectrum anti-fungal agent and Minocycline is used to treat bacterial infections including respiratory tract infections, infections of skin, genital and urinary systems. The company is headquartered in Melbourne, Australia. | Health Technology |
Mirrabooka Investments Ltd.
Mirrabooka Investments Ltd. Investment Trusts/Mutual FundsMiscellaneous Mirrabooka Investments Ltd. is closed-end investment fund/Investment trust. It invests in small and medium sized companies located in Australia and New Zealand. The company was founded in December 1998 and is headquartered in Melbourne, Australia. | Miscellaneous |
Pacific Dunlop Cables Group |
- Stock Market
- Insiders
- Craig Bottomley